Prelude Capital Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15,642
| Closed | -$46.9K | – | 1176 |
|
|
2023
Q3 | $46.9K | Sell |
15,642
-2,958
| -16% | -$8.87K | ﹤0.01% | 907 |
|
|
2023
Q2 | $45.8K | Buy |
18,600
+1,900
| +11% | +$4.67K | ﹤0.01% | 859 |
|
|
2023
Q1 | $37.7K | Buy |
+16,700
| New | +$37.7K | ﹤0.01% | 923 |
|
|
2020
Q1 | – | Sell |
-121
| Closed | -$5K | – | 1451 |
|
|
2019
Q4 | $5K | Buy |
+121
| New | +$5K | ﹤0.01% | 1298 |
|